Phase I/II adenoviral p53 gene therapy for chemoradiation resistant advanced esophageal squamous cell carcinoma.
Shimada H, Matsubara H, Shiratori T, Shimizu T, Miyazaki S, Okazumi S, Nabeya Y, Shuto K, Hayashi H, Tanizawa T, Nakatani Y, Nakasa H, Kitada M, Ochiai T.
Shimada H, et al. Among authors: shuto k.
Cancer Sci. 2006 Jun;97(6):554-61. doi: 10.1111/j.1349-7006.2006.00206.x.
Cancer Sci. 2006.
PMID: 16734736
Free PMC article.
Clinical Trial.